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ABSTRACT
Background: The histamine releasing test which detects histamine released from basophils in vitro is safe,
sensitive and widely used for clinical examination in the field of allergy. However, basophils of certain individu-
als do not release histamine, because of dysfunctions in their intracellular signal transduction (non-responder).
To overcome potential shortcomings of the histamine releasing test, we applied surface plasmon resonance
(SPR) to detect the activation of basophils.
Methods: Basophils of patients with allergy, and those of non-allergic volunteers were isolated from peripheral
blood. A batch of basophils obtained from a healthy volunteer was treated with lactic acid and IgE of a patient
with atopic dermatitis in order to replace their endogenous IgE. They were fixed on the sensor chip of the SPR
apparatus, pretreated with or without various inhibitors for intracellular signal transduction, and exposed to the
antigens or anti-IgE antibody.
Results: When basophils were sensitized with antigen specific IgE, they immediately caused the increase of
resonance angle (AR) in response to either anti-IgE antibody or corresponding antigens, even when they did
not release histamine. Moreover, the dose dependent reactions of basophils were reflected by the increase of
AR as well as the release of histamine. The increase of AR in response to anti-IgE antibody was reduced by
pre-treatment of basophils with inhibitors for intracellular signal transduction, but not more than the level for his-
tamine release.
Conclusions: SPR biosensors may be superior to the histamine release test for studying functions of human
basophils including those not releasing histamine.
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INTRODUCTION
The identification of antigen that provokes mast cell
activation is crucial to avoid anaphylactic shock and
the aggravation of atopic diseases, such as atopic der-
matitis, allergic rhinitis and asthma. The detection of
antigen specific IgE in serum implies hypersensitivity
against the antigen. Thus, a variety of immunological
methods, such as CAP-RASTTM, Ala-STATTM and AD-
VIA CentaurTM, to detect antigen specific IgE have
been developed and utilized in clinical practice.1 How-
ever, there are often substantial discrepancies be-
tween these serological tests and clinical symptoms.1
In vivo tests, such as skin tests and antigen challenge
tests, are more reliable in reflecting the clinical sce-
nario. However, these tests may be painful, and could
potentially evoke anaphylactic shock when a patient
is extremely sensitive to a particular antigen.2 More-
over, the intradermal injection of an antigen may sen-
sitize subjects who are not sensitive to the antigen.
Both mast cells and basophils in subjects sensitized
with the same repertoire of IgE release histamine in
response to the antigen. Therefore, the in vitro hista-
mine release test with basophils of peripheral blood is
sensitive, safe and gives reliable information regard-
ing antigen that causes type I hypersensitivity.
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Fig. 1 Principle of the activation of basophils via the high afinity IgE re
ceptor and analysis of SPR signals. Basophils were fixed to the surface of 
gold layer coated on a glass plate. The laser beam is directed toward the 
cel via a prism and reflected from there to the monitor which detects the 
shift of the resonance angle. The angle of resonance is proportional to the 
reflex index in the evanescent field, a few hundred nanometers from the 
surface. The reflex index reflects the amount (density) of the molecules in 
the evanescent field.
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Griese et al.3 reported that the histamine release
test showed higher sensitivity and specificity than the
skin test or RAST analysis based on the comparison
with bronchoprovocation of extrinsic asthmatic chil-
dren. However, basophils of a certain population of in-
dividuals, who showed type I hypersensitivity in vivo,
do not release histamine upon the activation of the
IgE receptors in vitro.4 Except for the histamine re-
lease from basophils, there is no apparent clinical dif-
ference between such patients and ordinary basophil-
reactive subjects.
The surface plasmon resonance (SPR) biosensor
detects a change of the reflex index on the surface of
a sensor chip in a real time fashion with high sensitiv-
ity. Therefore, it has been widely utilized for the
analysis of binding and dissociation of a ligand to its
receptor fixed on a sensor chip.5 We recently found
that degranulation of mast cells on the sensor chip
caused unexpectedly large changes of SPR signal.6,7
In this study we developed a method to detect baso-
phil activation by a SPR biosensor (Fig. 1).
METHODS
REAGENTS
Chemicals were from the following sources: human
serum albumin (HSA), 4,4’-dithio dibutyric acid
(DDA), N-hydroxysuccinimide (NHS), and 1-Ethyl-3-
(3-dimethylaminopropyl)-carbodiimide (EDC) from
Sigma-Aldrich Japan (Tokyo, Japan); genistein,
piceatannol, PP1 and wortmannin from Calbiochem
(San Diego, CA, USA); fetal calf serum (FCS) from
Biowest (Paris, France); RPMI-1640 medium, DMEM
and penicillin streptomycin liquid from Invitrogen
(Carlsbad, CA, USA); Goat anti-human IgE antibody
from Seikagaku Co. (Tokyo, Japan). BA312 antibody8
was kindly provided by Shionogi Pharmaceutical,
Co., Ltd. (Osaka, Japan) and was used for capturing
basophils on sensor chips. A monoclonal antibody
(25H3) against human IgE was provided as a kind gift
from Wakunaga Pharmaceutical Co., Ltd. (Osaka, Ja-
pan) and was used for purification of human IgE from
a serum of a patient with atopic dermatitis. Mite anti-
gen (300 AUml) in 0.04% phenol and 0.05% glycerol
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Table 1 Values of total serum IgE and CAP-RAST scores 
of subjects
CAP-RAST scoreTotal IgE (IU/mL)Subject
n.d.n.d.Atopic dermatitis 1
mite 48659Atopic dermatitis 2
mite 4237Alergic rhinitis 1
mite 4273Alergic rhinitis 2
mite 4270Alergic rhinitis 3
n.d.726Psoriasis
n.d.800Prurigo
soybean 3809Soybean alergy
n.d.25Healthy control 1
n.d.160Healthy control 2
n.d.n.d.Healthy control 3
n.d.: not done
was purchased from the Bayer Corporation (Elkhart,
IN, USA). Semi-purified sweat antigen was prepared
as reported previously.9 Soybean antigen was pre-
pared by gel filtration chromatography from the
water-extract of soybean. Ten grains of soybean were
soaked in water overnight, homogenized in 30 millili-
ters of phosphate-buffered saline (PBS), and filtered
by means of a strainer (70 μm pore-size; Becton,
Dickinson and Company, Bedford, MA, USA), fol-
lowed by membrane filtration (0.22 μm pore-size; Mil-
lipore, Billerica, MA, USA). The resulting extract was
gel-filtrated with Superdex 75 PC 3.230TM using the
SMARTTM system (GE Healthcare Bio-sciences KK;
Tokyo, Japan), at a flow rate of 50 μlmin. Twenty mi-
croliters of eluted fractions were subcutaneously in-
jected into a patient with soybean allergy. The frac-
tions that caused wheal and flare reactions of the pa-
tient were pooled and used as a stimulant of the
histamine-release test and SPR analysis. All stimu-
lants and their vehicles were appropriately diluted
with the buffer for histamine release assays as de-
scribed previously.6
SUBJECTS
The following subjects were included in this study:
two patients with atopic dermatitis, (atopic dermatitis
1, 2), three patients with allergic rhinitis, (allergic
rhinitis 1―3), a patient with soybean allergy (soybean
allergy), a patient with psoriasis vulgaris (psoriasis),
a patient with prurigo nodularis (prurigo), and three
healthy volunteers without apparent allergic symp-
toms, (healthy control 1―3). The amounts of antigen-
specific IgE in sera of the patients were measured us-
ing CAP-RASTTM.1 Values of total and antigen-
specific IgE of the subjects (patients and healthy vol-
unteers) are shown in Table 1. The protocol of the
study was approved by the ethics committee of the
Faculty of Medicine at Hiroshima University. All pa-
tients and volunteers were informed of the aim and
protocol and agreed to participate in the study.
HISTAMINE RELEASE ASSAY
Histamine release assays were carried out as re-
ported previously.9 Briefly, peripheral blood leuko-
cytes containing approximately 1% basophils were ob-
tained from patients and from healthy volunteers.
Mite antigen, soybean antigen and sweat antigen
were used as the stimulants in the histamine release
test. A goat anti-human IgE antibody (Seikagaku Co.,
Tokyo, Japan) was used as a positive control for these
assays at a 3,000-fold dilution. To study the effect of
inhibitors for intracellular signal transduction, cells
were preincubated with indicated concentrations of
genistein, piceatannol or PP1 for 30 minutes or wort-
mannin for 10 minutes at 37℃, and consequently in-
cubated with buffer, antigen or anti-IgE antibody in
the presence of the inhibitors. Histamine was ex-
tracted and measured by reverse-phase HPLC.
ISOLATION OF BASOPHILS FROM PERIPHERAL
BLOOD
Fourteen milliliters of venous blood were collected by
venopuncture using EDTA2Na containing tubes
(VacutainerTM; Becton-Dickinson and Company,
Franklin Lakes, NJ, USA) and separated by Ficoll-
HypaqueTM (GE Healthcare Bio-sciences KK; Tokyo,
Japan) density gradient centrifugation to isolate
mononuclear cells. Basophils were then semi-purified
from the mononuclear cell suspension using a baso-
phil isolation kit and an automated magnetic cell
sorter (autoMACSTM; Miltenyi Biotec GmbH, Ber-
gisch Gladbach, Germany) according to the manufac-
turer’s instructions. The basophil isolation kit em-
ployed a cocktail of antibodies against CD3, CD7,
CD14, CD15, CD16, CD36, CD45RA and HLA-DR to
deplete non-basophils and isolate untouched baso-
phils from the mononuclear cells. The basophils were
then washed and centrifuged twice in the buffer for
perfusion (0.8% NaCl, 0.02% KCl, 0.52mM NaH2PO4,
10mM HEPES, 0.1% Glucose, 2mM CaCl2, 1mM
MgCl2, 0.03% HSA, pH 7.4), which was also used for
the histamine release assay. Using Kimura’s staining
method, the purity of the obtained basophils was
found to be greater than 50%.10
MONITORING OF BASOPHIL ACTIVATION US-
ING SPR
SPR signals generated in the presence of basophils
with or without stimulants were analyzed using an
SPR apparatus, SPR-CELLIATM (Moritex Corpora-
tion, Tokyo, Japan). Sensor chips (27 × 20 mm) with
50-nm thick gold films were sterilized with 70% etha-
nol and chemically activated according to the manu-
facturer’s instructions.7 Seventy microliters of anti-
basophilic antibody (BA312, 100 μgml) were placed
on two spots on the activated surface of a sensor chip
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and incubated for 10 minutes at room temperature.
After washing of the surface with PBS, 50―70 μl of ba-
sophil suspension (containing approximately 2.3 × 104
to 1.25 × 105 cells) in buffer was placed on the area
treated with BA312 antibody. A half to three hours
later, the sensor chip with basophils was rinsed with
buffer, and preincubated in the presence or absence
of 100 μM genistein, 100 μM piceatannol or 10 μM
PP1 for 30 minutes or 10 nM wortmannin for 10 min-
utes in CO2-incubator at 37℃. The sensor chip was
then rinsed with buffer and positioned in a flow-cell
unit of the SPR apparatus with two chambers. The
cells placed in the chambers were perfused with
buffer at a flow rate of 10 μlmin for IgE sensitization
or 20 μlmin in all other experiments. Buffer with or
without stimulants was injected from the side of the
inlet at the same rate of flow as that in the pre-
incubation stage.
PURIFICATION OF IgE FROM THE SERUM OF A
PATIENT WITH ATOPIC DERMATITIS
IgE was affinity purified from the sera of a patient
with atopic dermatitis, whose peripheral leukocytes
released histamine by the mite antigen (described be-
low). Anti-human IgE antibody (25H3) was coupled
to NHS-activated Sepharose 4FF (GE Healthcare Bio-
Sciences KK, Tokyo, Japan) according to the manu-
facturer’s instructions. The gel was equilibrated in
PBS and packed onto a 1 × 5 cm column (econo-
columnTM, Bio Rad, Hercules, CA, USA) (human IgE
affinity-column). The serum was diluted with two vol-
umes of PBS and applied to the affinity-column. After
washing the column thoroughly with PBS, the IgE
antibody was eluted with 0.1M glycine-HCl buffer
(pH 2.5). To neutralize the pH immediately, 1 millili-
ter of each fraction was collected in a tube containing
0.25 milliliters of phosphate buffer (2M, pH 7.2). IgE-
containing fractions were pooled, filtered (0.22 μm fil-
ter) (Millex-GVTM, Millipore Corp., Bedford, MA,
USA), and stored at 4℃ until use. The purity of the
IgE preparation was confirmed (approximately >95%)
by sodium dodecyl sulfate-polyacrylamide gel electro-
phoresis (SDS-PAGE).
REMOVAL OF IgE AND PASSIVE SENSITIZA-
TION OF BASOPHILS WITH THE PATIENT’S IgE
To study whether the SPR signals provoked by stimu-
lation of basophils with antigens were mediated by
IgE or not, we utilized healthy volunteers’ basophils
that released histamine in response to anti-IgE anti-
body, but not to mite antigen. Basophils of healthy
volunteers were treated with lactic acid to remove en-
dogenous IgE and passively sensitized with purified
IgE of patients with atopic dermatitis (AD-IgE) as de-
scribed previously.9,11
RESULTS
SPR SIGNALS SHOW THE INCREASE OF AR IN
RESPONSE TO STIMULI THAT INDUCED HISTA-
MINE RELEASE.
Basophils were prepared from a patient with atopic
dermatitis (atopic dermatitis 1), two patients with al-
lergic rhinitis with mite-specific IgE (allergic rhinitis
1, 2) and an apparently healthy volunteer (healthy
control 1). The dermatitis of the patient with atopic
dermatitis was aggravated after sweating, whereas
the healthy volunteer did not experience any skin
problems even after profuse sweating. The basophils
were either fixed on a sensor chip for SPR apparatus
or suspended in assay tubes for the histamine release
test, and exposed to appropriate stimuli or vehicles.
When basophils of a patient with allergic rhinitis (al-
lergic rhinitis 1) were exposed to anti-IgE antibody
on the sensor chip for SPR apparatus, the angle of
resonance (AR) rapidly increased for 5 to 10 minutes
and was sustained at a high level or further continued
to increase (Fig. 2a). The injection of buffer or goat
IgG with the same isotype antibody as anti-IgE anti-
body caused no, or only transient and minute change
of the AR, regardless of the presence of basophils on
the sensor chip (Fig. 2a). The change of AR with vari-
ous concentrations of anti-IgE antibody and that of
mite antigen increased in a dose dependent manner
(Figs. 2a, c). Anti-IgE antibody and mite antigen also
induced histamine release from the basophils in as-
say tubes in a dose dependent manner (Figs. 2b, d).
Similar results were obtained with basophils of an-
other patients with allergic rhinitis (allergic rhinitis 2)
and those with atopic dermatitis (atopic dermatitis 1)
(data not shown).
Specificity of the reaction detected by SPR was fur-
ther studied with basophils of allergic and non-
allergic donors and various antigens. Basophils of the
patient with atopic dermatitis 1 showed the increase
of AR and histamine release in response to sweat anti-
gen as those of the patients with allergic rhinitis
stimulated with anti-IgE antibody or mite antigen
(Figs. 3a, b). However, no change of AR or histamine
release was induced when basophils of healthy con-
trol 1 were exposed to the sweat, mite or soybean an-
tigens (Figs. 3b, c, d).
SPR SIGNALS OBTAINED FROM BASOPHILS
OF A HEALTHY VOLUNTEER THAT WERE PAS-
SIVELY SENSITIZED WITH AD-IgE.
Basophils of a healthy volunteer (healthy control 1)
were treated with lactic acid to remove endogenous
IgE, and then were immobilized on a sensor chip. Af-
ter washing with running buffer, the basophils were
passively sensitized with AD-IgE in the flow cell dur-
ing the period indicated by the first horizontal bar.
Exposure of the cells to AD-IgE(20 μgml, or 50 μg
ml) induced a subtle increase in the SPR signal, but
SPR Sensor Detecting Basophil Activation
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Fig. 2 SPR signals and histamine release by basophils of a patient with alergic rhinitis. Basophils of a pa-
tient with alergic rhinitis (alergic rhinitis 1, CAP-RASTTM score 4 for mite antigen) were immobilized on two 
spots of a sensor chip equipped in a flow-cel unit of the SPR apparatus (a, c) or suspended in tubes for his-
tamine release tests (c, d). (a) The basophils were washed with running bufer, and then exposed to various 
concentrations of anti-human IgE antibody (anti-IgE), goat IgG as an isotype-control antibody, or a vehicle 
(running bufer itself) for antibodies, during the periods indicated by a horizontal bar. The control experiments 
were performed without basophils in the same manner. Angles of resonance (AR) were measured during the 
perfusion and then changes were ploted against time (Change of AR). (b) The leucocytes containing baso-
phils obtained from the donor were stimulated with various concentrations of anti-human IgE antibody or the 
goat IgG. The amount of histamine was measured by the HPLC system, as described in the Materials and 
Methods section. (c) Basophils were washed, exposed to various concentrations of mite antigen or a vehicle 
(0.04% phenol and 0.05% glycerol) for mite antigen, during the periods indicated by a horizontal bar. (d) The 
leucocytes were stimulated with various concentrations of mite antigen or vehicle (0.04% phenol and 0.05% 
glycerol) appropriately diluted with the bufer. Similar results shown in (a―d) were obtained with the basophils 
of another patient with alergic rhinitis (alergic rhinitis 2) and those with atopic dermatitis 1 (data not shown).
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did not induce any significant increase in the signal
by the end of the period. After rinsing the loosely at-
tached IgE with running buffer, mite antigen was per-
fused into the flow cell during the periods indicated
by the second horizontal bar. The mite antigen in-
duced a robust increase of AR, which continued even
after the exposure was terminated. Moreover, a
larger increase of AR was induced when basophils
were sensitized with a higher concentration (50 μg
ml) of AD-IgE (Figs. 4a, b). However, neither signifi-
cant change of SPR signal nor histamine release was
induced by mite antigen, when cells were not ex-
posed to AD-IgE (Figs. 4a, b; broken line). The baso-
phils treated with lactic acid and passively sensitized
with AD-IgE released histamine in response to mite
antigen (Fig. 4C).
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Fig. 3 Specificity of the reaction of basophils obtained from alergic and non-alergic donors against various 
antigens. (a) Basophils of a patient with atopic dermatitis (atopic dermatitis 1) (solid line) and those of a 
healthy volunteer (healthy control 1) (broken line) were exposed to sweat antigen during the periods indicated 
by a horizontal bar. (b) Leucocytes of the same donors were stimulated with anti-human IgE antibody (anti-
IgE), sweat antigen, or bufer. (c) Basophils of the healthy volunteer (healthy control 1) were exposed to anti-
IgE antibody, mite antigen, soybean antigen during the periods indicated by a horizontal bar. Bufer 1 is the 
running bufer itself and utilized for dilution of anti-IgE antibody, sweat antigen and soybean antigen. Bufer 2 
contained 0.04% phenol and 0.05% glycerol in Bufer 1 and was used for dilution of mite antigen. (d) Leuco-
cytes of the healthy volunteer were stimulated with the same stimuli employed in the experiment in (c).
SPR SIGNALS DETECT THE CHANGES OF AR
IN RESPONSE TO STIMULI ON BASOPHILS
THAT DO NOT RELEASE HISTAMINE.
To further investigate whether the SPR sensor may
detect any sign of reaction of basophils that do not
show histamine release in standard tests, we studied
the change of AR with such basophils in response to
anti-IgE antibody and antigens. Seven donors were
recruited for this study; two healthy volunteers
(healthy control 2, 3), two patients with non-allergic
skin diseases (psoriasis and prurigo), and three pa-
tients with allergic disorders (allergic rhinitis 3,
atopic dermatitis 2, and a patient with soybean al-
lergy). The sensitivities of the allergic patients for re-
spective antigens were also diagnosed by clinical epi-
sodes. Basophils of all these donors released no or
only marginal amounts of histamine in response to
anti-IgE antibody or respective antigens (Figs. 5b, d, f
and Figs. 6b, d). However, they all caused the prompt
increase of AR in response to anti-IgE antibody (Figs.
5a, c, e and Figs. 6a, c). Basophils of the patients with
atopic dermatitis and those with soybean allergy also
caused apparent increases of AR in response to re-
spective stimuli (Figs. 6a, c). Similar results were ob-
tained with basophils of healthy control 3 for stimula-
tion by anti-IgE antibody or with basophils of the pa-
tient with atopic dermatitis 2 for stimulation by mite
antigen (data not shown) . The degrees and durations
of the increase of AR in response to the stimuli were
dependent on the donor of basophils andor the kind
SPR Sensor Detecting Basophil Activation
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Fig. 4 SPR signals obtained from basophils of a healthy volunteer that were passively sensitized with AD-
IgE. Basophils of a healthy volunteer (healthy control 1) were treated with lactic acid to remove endogenous 
IgE and immobilized on a sensor chip. (a, b) The basophils were passively sensitized with or without purified 
IgE of a patient with atopic dermatitis (AD-IgE) (a; 20 μg/ml, b; 50 μg/ml) during the periods indicated by the 
first horizontal bar at flow rate of 10 μl/min. After a rinse by perfusion with running bufer, the cels were then 
exposed to mite antigen during the periods indicated by the second horizontal bar at flow rate of 20 μl/min. An 
arow head indicates the changing point of flow rate. (c) The amounts of histamine released from basophils 
obtained from the same donor and stimulated with anti-human IgE antibody (anti-IgE) or mite antigen. Closed 
columns indicate the amounts of histamine released from basophils without lactic acid treatment. Open col-
umns show those treated with lactic acid folowed by re-sensitization with AD-IgE.
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of stimuli. These variations of the SPR signal evoked
by basophils may be due to the variations of the cell
numbers fixed on a sensor chip, andor heterogene-
ity of the signal transductions adjacent to the plasma
membrane, including those specifically detected by
SPR. In any case, the changes were clear enough to
be distinguished from those with basophils exposed
to the buffer alone.
EFFECTS OF VARIOUS INHIBITORS FOR INTRA-
CELLULAR SIGNAL TRANSDUCTION ON HISTA-
MINE RELEASE AND SPR SIGNALS.
To elucidate the molecular mechanism of SPR signals
raised by basophil activations, we pre-treated baso-
phils with various inhibitors of intracellular signal
transduction; genistein, a tyrosine kinase inhibitor;
piceatannol, a Syk inhibitor; PP1, a Src tyrosine
kinase inhibitor, and wortmannin, a PI3 kinase inhibi-
tor. The histamine release in response to anti-IgE an-
tibody was inhibited in a dose-dependent manner by
all reagents. SPR signals derived from basophils in re-
sponse to anti-IgE antibody were also impaired by
these inhibitors (Fig. 7). Degrees of inhibition in both
histamine release and SPR signals were variable
either by the type of inhibitors or donors of basophils
(n = 3). However, inhibition of SPR signal never ex-
ceeded those of histamine release (Fig. 7).
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Fig. 5 SPR signals obtained from basophils of a healthy control or non-alergic patients that re-
lease no or marginal amounts of histamine. Basophils obtained from a healthy volunteer (healthy 
control 2) (a, b) and those from a patient with psoriasis vulgaris (c, d), and pruritus nodularis (e, f) 
were stimulated with anti-human IgE antibody (anti-IgE) as experiments shown in Figures 2―4. No 
or only marginal amounts of histamine release were detected (b, d, f). However, various degrees 
of increases in AR were observed in response to the stimulation with anti-human IgE antibody (a, 
c, e). Similar results were obtained with basophils of another donor (healthy control 3) (data not 
shown).
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Fig. 6 SPR signal obtained from basophils of patients with alergy that release no or marginal 
amounts of histamine. Basophils obtained from a patent with alergic rhinitis (alergic rhinitis 3) 
with mite-specific IgE (CAP-RASTTM score 4) (a, b) and a patient with soybean alergy with 
soybean-specific IgE (CAP-RASTTM score 3) (c, d) were stimulated with anti-human IgE antibody 
(anti-IgE) or respective antigens. After a rinse with running bufer, the stimulants were perfused 
onto/into the flow cel during the periods indicated by the coresponding horizontal bars (■; anti-
IgE antibody, □ ; soybean antigen) (a, c) . No or only marginal amounts of histamine were re-
leased in response to either stimulation (b, d) . However, substantial amounts of increase in AR 
were observed in response to anti-IgE antibody and antigens (a, c). Similar results were obtained 
with basophils of a patient with atopic dermatitis (atopic dermatitis 2) (data not shown).
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DISCUSSION
Basophils and mast cells release histamine in re-
sponse to antigens or anti-IgE antibody and cause
anaphylactic symptoms. In this study, we have dem-
onstrated that the SPR biosensor detects the change
of AR due to the activation of human basophils in
both a dose-dependent and real time manner. The
change of AR was initiated in a few minutes and sus-
tained for 10 to 30 minutes or longer. Moreover, such
reactions were detected by an SPR sensor, even
when no apparent reaction of the cells was detected
by the standard histamine release test.
The plasmon in a metal layer surface may be
resonated with a laser beam irradiated from the other
side of the layer with a certain inward angle (angle of
resonance; AR) (Fig. 1). The AR is determined by the
reflex index in the field of evanescence (ca 600 nm)
on the metal and can be measured via the analysis of
reflected light spectrum. The reflex index in the field
of evanescence proportionally increases in accor-
dance to the binding of biomolecules, such as pro-
tein, lipid and nucleic acid. Therefore, SPR has been
widely utilized for sensors to analyze the binding and
dissociation of ligands to and from their receptors in
real time without labeling.
We recently found that living cells on the sensor
chip caused unexpectedly large change of AR when
the cells were activated under physiological condi-
tions. The increase of AR was barely induced by the
Suzuki H et al.
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Fig. 7 Efects of various inhibitors for intracelular signal transductions on histamine release 
and SPR signals. Basophils of patients with alergic rhinitis (alergic rhinitis 1) were immobi-
lized on a sensor chip (a, c, e, g) or suspended in assay tubes (b, d, f, h) and pretreated in the 
presence or absence of indicated concentrations of genistein (a, b), piceatannol (c, d) or PP1 
(e, f) for 30 minutes or wortmannin (g, h) for 10 minutes at 37℃, and then exposed to anti-hu-
man IgE antibody (anti-IgE). Both histamine release and SPR signals were impaired by pre-
treatment with inhibitors. When basophils were prepared from two other donors (healthy 
control 1 and alergic rhinitis 2), degrees of the impairment were either large or smal as com-
pared with results shown in this figure. However, those on SPR signals were always partial 
and have never been larger than those of histamine release.
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binding of monomeric IgE or hapten to RBL-2H3
mast cells, which does not cause exocytosis. How-
ever, a consequential binding of antigens that bind to
IgE and aggregate FcεRI on RBL-2H3 cells induced a
large increase of AR.6 A similar change of AR in re-
sponse to the antigen was detected even when the
change of cell structure and movement was inhibited
by pre-treatment with actin polymerization inhibitors,
Toxin B or mycaloride.7 On the other hand, the
changes of AR were abolished when cells were pre-
treated with genistein, a tyrosine kinase inhibitor that
prevents the intracellular signal transduction initiated
by the activation of FcεRI. Moreover, activation of the
adenosine A3 receptor on RBL-2H3 cells also induced
a sustained increase of AR. This stimulation induced
only a marginal amount of exocytosis by itself, but
showed a large synergistic effect on antigen-induced
exocytosis.6 These results suggest that SPR reflects
early events of intracellular signal transduction rather
than the exocytosis or morphological changes of
mast cells, detectable by light microscopy. In this
study, we have demonstrated that human basophils
also induce a similar change of AR when stimulated
with antigen after proper sensitization with IgE. The
reaction was detected even with basophils that did
not release histamine in spite of the IgE sensitization
for antigen (Figs. 5, 6). Recently, Fang et al.12 also re-
ported the change of local reflex index by the activa-
tion of living cells without exocytosis. They employed
the technique of resonant waveguide grating to ana-
lyze the reactions of epidermoid carcinoma A431 cells
in response to epidermal growth factor (EGF) and
bradykinin via EGF receptors and bradykinin B2 re-
ceptors, respectively.
The assays of serum-IgE titer and allergen-specific
IgE titer have been used for the diagnosis of type I
hypersensitivity. However, these do not represent the
allergic symptoms themselves and do not necessarily
reflect the functional hypersensitivity of patients. On
the other hand, the histamine released from baso-
phils andor mast cells is an important mediator that
causes allergic symptoms, by directly acting on blood
vessels, nerves, glands and trachial smooth muscles.
Therefore, the histamine release test with basophils
in vitro is a reliable and safe examination for the state
of allergy.13 However, it has been known that baso-
phils of some individuals (non-responders) do not re-
lease histamine upon the activation of their high affin-
ity IgE receptors (FcεRI).5 The mechanism of such
functional insufficiency is not fully clear. Kepley et al.
reported that such basophils failed to express syk
protein, a tyrosine kinase which binds and phospho-
rylates the γ-subunit of FcεRI,14 but they release his-
tamine when activated by non-IgE mediated stimuli
such as calcium ionophores, which circumvent the
cell surface receptor. Moreover, Lavens-Phillips et
al.15 found that basophils of non-responders have at
least 10-fold less protein expression of lyn and syk
kinases compared with basophils of ordinary indi-
viduals. On the other hand, Vonakis et al.16 have
shown that basophils of patients with chronic idi-
opathic urticaria fail to release histamine due to the
increased expression of Src-homology 2-containing-5’-
inositol phosphatases (SHIPs).
Since SPR detects changes that affect the reflex in-
dex in the near field of the sensor chip, it should de-
tect the kinetics of molecules associated with plasma
membrane regardless of their enzymatic activities.
This may include the aggregation of FcεRI, the asso-
ciation of signaling molecules, including phos-
phatases and raft formation in the plasma membrane.
Pre-treatment of basophils with genistein, a tyrosine
kinase inhibitor; piceatannol, a Syk inhibitor; PP1, a
Src tyrosine kinase inhibitor; or wortmannin, a PI3
kinase inhibitor, impaired the increase of AR to vari-
ous degrees. The increase of AR was almost abol-
ished as well as histamine release by wortmannin, es-
pecially in a late phase of the reaction, suggesting
that the activation of PI3 kinase andor its down-
stream signals in basophils were largely reflected by
SPR signals (Fig. 7g). Although both degrees of inhi-
bition of histamine release and those of SPR signals
by the other inhibitors were variable among donors
for basophils, effects of inhibitors on SPR signal
never exceeded those of histamine release in all ex-
periments.
A possible explanation for such discrepancies be-
tween the inhibitory effects on histamine release and
those on SPR signals may be a difference between
the threshold for histamine release and that for SPR
signals, or the events contribute to histamine release
and those to SPR signals. SPR signal should reflect
any change of molecular mass distribution in the field
of evanescence regardless of their biological activi-
ties. On the other hand, histamine release is induced
only when positive signaling activities, such as the
phosphorylation of tyrosine kinases and the increase
of intracellular calcium, become superior to negative
signaling activities, such as the activation of phos-
phatases including SHIP-1 and SHIP-2. Thus, it is fea-
sible that SPR signals reflect cellular reactions more
sensitively than whole cell functions, such as media-
tor release and morphological changes. We recently
investigated contributions of intracellular signaling
molecules on SPR signals induced by antigen in RBL-
2H3 cells. In that study, we identified PKCβ as a key
molecule for the increase of AR by techniques of
siRNA and overexpression.17 Further studies are nec-
essary to confirm whether it is applicable for human
basophils.
A biosensor with a cell-electrode, based on the
semiconductor technology was developed18 and also
applied to the detection of real-time monitoring of
IgE-mediated mast cell activation. The impedance of
a RBL-2H3 cell-attached electrode correlated with the
morphological change of and the release of
Suzuki H et al.
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β-hexosaminidase from the cells. However, precise
relations between molecular events in the cell and the
impedance of cell-attached electrode were also un-
clear. Therefore, the SPR-based cell sensor should be
superior to the cell-electrode sensor in that it detects
the reactions of non-adhering cells, including baso-
phils that do not complete histamine release.
The limitations of the present method for practical
use are the time and the amount of blood needed to
obtain basophils for the analysis; namely three hours
and 14 milliliters blood for each course of the kinetic
studies. However, once basophils are obtained and lo-
cated in the SPR-biosensor, their reactions to various
stimuli are detected rapidly and sensitively, even for
those of non-responders. The development of a
method for the rapid isolation of basophils and down-
sizing of the SPR apparatus would be beneficial. This
approach will result in the sensor becoming a useful
tool for detecting some events of the activation of hu-
man basophils, not only for basic scientific research
but also for the purpose of clinical examinations.
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